In their first description by Singh et al. in 2012, FGFR3-TACC3 (thereafter F3T3) fusions were detected from the transcriptome of cultured glioma cells obtained from nine GBM patients [3]. The gene discussed is FGFR3; the disease is central nervous system cancer.